|
Market Closed -
Other stock markets
|
After hours 21:00:00 | |||
| 10.70 EUR | -0.19% |
|
10.70 | -0.07% |
| 12-04 | Grifols achieves self-sufficiency in plasma-derived medicines in Egypt | RE |
| 12-03 | European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 12 | ||||||||
| 26 | ||||||||
| 16 | ||||||||
| 18 | ||||||||
| 25 | ||||||||
| 29 | ||||||||
| 20 | ||||||||
| 25 | ||||||||
| 5 | ||||||||
| - | - | |||||||
| 17 | ||||||||
| 11 | ||||||||
| 18 | ||||||||
| 11 | ||||||||
| 25 | ||||||||
| 11 | ||||||||
| - | 1 | |||||||
| 20 | ||||||||
| 10 | ||||||||
| Average | 17 | |||||||
| Weighted average by Cap. | 20 |
- Stock Market
- Equities
- GRF Stock
- Sector Grifols, S.A.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















